Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer

European Journal of Cancer

Volumn 48, Issue 9, 2012, Pages 1332-1340

  Torfs, Sofie ^a   Cadron, Isabelle ^a   Amant, Frederic ^a   Leunen, Karin ^a   Berteloot, Patrick ^a   Vergote, Ignace ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Advanced; Carboplatin; Cervical cancer; Cervix; Chemotherapy; Neoplasms; Paclitaxel; Recurrent; Treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL; TOPOTECAN;

ADULT; AGED; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REDUCTION; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPERSENSITIVITY; METASTASIS; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; THROMBOCYTOPENIA; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84861338474     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.01.006     Document Type: Article

References (34)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer cases incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. I. Cadron, T. Van Gorp, and F. Amant Chemotherapy for recurrent cervical cancer Gynecol Oncol 107 2007 S113 S118
3. D.H. Moore, J.A. Belssing, and R.P. Mcquellon Phase III study of cisplatin with or without paclitaxel in stage IV b, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study J Clin Oncol 22 2004 3113 3119
4. B.J. Monk, M.W. Sill, and D.S. McMeekin Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 27 2009 4649 4655
5. H.J. Long III, B.N. Bundy, and E.C. Grendys Jr Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study J Clin Oncol 23 2005 4626 4633
6. T. Thigpen, H. Shingleton, and H. Homesley Cisplatinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the gynecologic oncology group Cancer 48 1981 899 903
7. J.T. Thigpen, J.A. Blessing, and P.J. Disaia A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncolgy Group Study Gynecol Oncol 32 1989 198 202
8. S.B. Lele, and M.S. Piver Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma Gynecol Oncol 33 1989 6 8
9. P. Bonomi, J.A. Blessing, and F.B. Stehman Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study J Clin Oncol 3 1985 1079 1085
10. B. Reichman, M. Markman, and T. Hakes Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy Gynecol Oncol 43 1991 159 163
11. A. du Bois, H.J. Luck, and W. Meier A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer J Natl Cancer Inst 95 2003 1320 1330
12. R.F. Ozols, F.N. Bundy, and B.E. Greer Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 21 2003 3194 3200
13. W.P. McGuire 3rd, J. Aresneau, and J.A. Blessing A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study J Clin Oncol 7 1989 1462 1468
14. G.R. Weiss, S. Green, and E.V. Hannigan A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest oncology group study Gynecol Oncol 39 1990 332 336
15. W.P. McGuire, J.A. Blessing, and D. Moore Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group Study J Clin Oncol 14 1996 792 795
16. C. Kosmas, N. Mylonakis, and G. Tsakonas Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer Br J Cancer 101 2009 1059 1065
17. G. Mountzios, M.A. Dimopoulos, and A. Bamias Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study Ann Oncol 20 2009 1362 1368
18. W. Termrungruanglert, A.P. Kudelka, and S. Piamsomboon Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature Eur J Gynaecol Oncol 17 1996 493 496
19. A.S. Sit, J.L. Kelley, H.H. Gallion, A.J. Kunschner, and R.P. Edwards Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix Cancer Invest 22 2004 477 478
20. K.N. Moore, T.J. Herzog, and S. Lewin A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer Gynecol Oncol 105 2007 299 303
21. M.S. Piver, S.A. Ghamande, G.H. Eltabbakh, and C. O'Neill-Coppola First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - a phase II study Gynecol Oncol 75 1999 334 337
22. A.A. Secord, L.J. Havrilesky, and M.E. Carney Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer Int J Clin Oncol 12 2007 31 36
23. A.V. Tinker, K. Bhagat, K.D. Swenerton, and P.J. Hoskins Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the Britisch Columbia Cancer Agency experience Gynecol Oncol 98 2005 54 58
24. D. Pectasides, G. Foutnzilas, and G. Papaxoinis Carboplatin and paclitaxel in metastatic or recurrent cervical cancer Int J Gynecol Cancer 19 2009 777 781
25. S. Mabuchi, K. Morishige, and M. Fujita The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitve radiotherapy Gynecol Oncol 113 2009 200 204
26. I. Saito, R. Kitagawa, and H. Fukuda A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: gynecologic cancer study group/Japan clinical oncology group Jpn J Clin Oncol 40 2010 90 93
27. P. Rosenberg, H. Andersson, and K. Boman Randomized trial of single agent paclitaxel given weekly versus every 3 weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum Acta Oncol 41 2002 418 424
28. M.C. Green, A.U. Muzdar, and T. Smith Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks J Clin Oncol 23 2005 5983 5992
29. M.A. Socinski, A. Ivanova, and K. Bakri A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-week carboplatin and weekly paclitaxel in advanced non-small cell cancer Ann Oncol 17 2006 104 109
30. T. Mori, K. Hosokawa, and M. Sawada Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer. Long term results Int J Gynecol Cancer 20 2010 611 616
31. P.G. Rose, N. Fusco, M. Smrekar, and K. Mossbruger Rodgruez. successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity Gynecol Oncol 89 2003 429 433
32. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
33. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic- applications/ctc.htm.
34. G. Zanetta, F. Fei, and G. Parma Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous cell cervical cancer Ann Oncol 10 1999 1171 1174